Manchester Capital Management LLC Amgen Inc Transaction History

Manchester Capital Management LLC

$829 Million
Q3 2024

A detailed history of Manchester Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Manchester Capital Management LLC holds 6,406 shares of AMGN stock, worth $1.89 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

6,406

Previous 6,346 0.95%

Holding current value

$1.89 Million

Previous $1.98 Million 4.14%

% of portfolio

0.25%

Previous 0.24%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$309.38 - $337.38 $18,562 - $20,242	60 Added 0.95%	6,406 $2.06 Million
Q2 2024 Aug 08, 2024	BUY	$262.75 - $319.31 $27,588 - $33,527	105 Added 1.68%	6,346 $1.98 Million
Q1 2024 May 06, 2024	SELL	$268.87 - $324.56 $19,089 - $23,043	-71 Reduced 1.12%	6,241 $1.77 Million
Q4 2023 Feb 08, 2024	BUY	$255.7 - $288.46 $60,089 - $67,788	235 Added 3.87%	6,312 $1.82 Million
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $117,633 - $146,045	-538 Reduced 8.13%	6,077 $1.63 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $91,279 - $107,935	426 Added 6.88%	6,615 $1.47 Million
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $1.4 Million - $1.7 Million	6,189 New	6,189 $1.5 Million
Q2 2022 Aug 10, 2022	SELL	$230.71 - $256.74 $978,671 - $1.09 Million	-4,242 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$219.27 - $242.57 $11,840 - $13,098	-54 Reduced 1.26%	4,242 $1.03 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $6,563 - $7,510	-33 Reduced 0.76%	4,296 $966,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $143,494 - $168,121	676 Added 18.51%	4,329 $921,000
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $934 - $1,036	-4 Reduced 0.11%	3,653 $890,000
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $11,539 - $13,447	52 Added 1.44%	3,657 $910,000
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $3,245 - $3,865	15 Added 0.42%	3,605 $829,000
Q3 2020 Oct 27, 2020	SELL	$234.65 - $260.95 $405,005 - $450,399	-1,726 Reduced 32.47%	3,590 $912,000
Q3 2019 Nov 04, 2019	SELL	$174.11 - $208.62 $17,933 - $21,487	-103 Reduced 1.9%	5,316 $1.03 Million
Q2 2019 Aug 05, 2019	SELL	$166.7 - $195.41 $50,010 - $58,623	-300 Reduced 5.25%	5,419 $999,000
Q1 2019 May 08, 2019	BUY	$180.87 - $203.88 $25,502 - $28,747	141 Added 2.53%	5,719 $1.09 Million
Q2 2018 Aug 08, 2018	BUY	$166.05 - $186.51 $26,401 - $29,655	159 Added 2.93%	5,578 $1.03 Million
Q1 2018 May 07, 2018	SELL	$169.43 - $198.0 $13,046 - $15,246	-77 Reduced 1.4%	5,419 $924,000
Q4 2017 Feb 08, 2018	BUY	$168.79 - $188.59 $30,382 - $33,946	180 Added 3.39%	5,496 $956,000
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $889,313 - $1.02 Million	5,316	5,316 $991,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Capital Management LLC with notifications on news.

Account

Manchester Capital Management LLC Amgen Inc Transaction History